Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xuesaitong Soft Capsule in unstable angina after coronary intervention
ChiCTR2000032152Phase 4Not yet recruiting
- Sponsor
- Xiyuan Hospital
- Start
- May 2020
- Countries
- 1
01
Overview
Phase 4, randomised trial of panax notoginseng in unstable angina (2 arms), sponsored by Xiyuan Hospital. Primary endpoint: high-sensitivity C-reactive protein. Planned start May 2020; status: not yet recruiting.
02
Drugs
panax notoginseng
03
Conditions
unstable angina
Beyond the preview
Go deeper on ChiCTR2000032152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032152.